Abstract
■ Preoperatively, risk factors should be analyzed, for example, type of uveitis, course of inflammation, basic diagnostic workup and complications like cystoid macular edema.
■ At the time of surgery, the eye should have been completely quiet for approximately 2–3 months.
■ Preoperative prophylaxis includes maintenance therapy, under which the eye remains quiet until surgery, and additional anti-inflammatory treatment beginning approximately 1–2 weeks prior to surgery, systemic or topical corticosteroids.
■ Intraoperatively, intravenous methylprednisolone or intravitreal triamcinolone acetonide can be very effective in high-risk patients in preventing postoperative complications.
■ Postoperative treatment should include systemic and topical corticosteroids, depending on the preoperative and intraoperative situation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bosch-Driessen LH, Plaisier MB, Stilma JS, van der Lelij A, Rothova A. Reactivation of ocular toxoplasmosis after cataract extraction. Ophthalmology 2002; 109: 41–45
Estafanous MFG, Lowder CY, Meisler DM, Chauhan R. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol 2001; 131: 620–625
Foster CS, Rashid S. Management of coincident cataract and uveitis. Curr Opin Ophthalmol 2003; 14: 1–6
Heiligenhaus A, Heinz C, Becker M. The treatment of uveitis cataract. In: Kohnen T, Koch D, editors. Cataract and Refractive Surgery. Berlin: Springer; 2005, pp. 133–152
Klais CM, Hattenbach LO, Steinkamp GW, Zubcov AA, Kohnen T. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children. J Cataract Refract Surg 1999; 25: 357–362
Kohnen T, Dick B, Hessemer V, Koch DD, Jacobi KW. Effect of heparin in irrigating solution on inflammation following small incision cataract surgery. J Cataract Refract Surg 1998; 24: 237–243
Li J, Heinz C, Zurek-Imhoff B, Heiligenhaus A. Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritis. J Cataract Refract Surg 2006; 32: 1535–1539
Matsuo T, Takahashi M, Inoue Y, Egi K, Kuwata Y, Yamaoka A. Ocular attacks after phacoemulsification and intraocular lens implantation in patients with Behcet’s disease. Ophthalmologica 2001; 215: 179–182
Meacock WR, Spalton DJ, Bender L, Antcliff R, Heatley C, Stanford MR, Graham EM. Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification. Br J Ophthalmol 2004; 88: 1122–1124
Okhravi N, Lightman SL, Towler HM. Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology 1999; 106; 710–722
Sanders DR, Kraff MC, Lieberman HL, Peyman GA, Tarabishy S. Breakdown and reestablishment of blood-aqueous barrier with implant surgery. Arch Ophthalmol 1982; 100: 588–590
Scheilian M, Karimean F, Javadi MA, et al. Surgical management of cataract and posterior chamber intraocular lens implantation in Fuchs’ heterochromic iridocyclitis. Int Ophthalmol 1997; 21: 137–141
Tabbara K, Chavis P. Cataract extraction in patients with chronic posterior uveitis. Int Ophthalmol Clin 1995; 35: 121–131
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zierhut, M., Szurman, P. (2008). Perioperative Medical Management. In: Becker, M., Davis, J. (eds) Surgical Management of Inflammatory Eye Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33862-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-540-33862-8_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33861-1
Online ISBN: 978-3-540-33862-8
eBook Packages: MedicineMedicine (R0)